Abstract
Melanoma (MLA) is aggressive and potentially lethal skin cancer, mostly when diagnosed in advanced stages. The MLA treatment is performed mainly by cytotoxic drugs limited by their high systemic toxicity, acquired resistance by tumor cells, and immunosuppression. In the search to find out new molecules capable of presenting a better response rate and with fewer side effects, products of n…